James Wooten. Show Affiliations »
Abstract
Mesh： See more » Antipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsAripiprazoleBenzodiazepines/adverse effectsClozapine/adverse effectsDiabetes Mellitus/chemically inducedDiabetes Mellitus/metabolismDibenzothiazepines/adverse effectsDyslipidemias/chemically inducedDyslipidemias/metabolismGlucose Metabolism Disorders/chemically inducedGlucose Metabolism Disorders/prevention & controlHumansInsulin ResistanceMental Disorders/drug therapyMental Disorders/metabolismObesity/chemically inducedObesity/metabolismOlanzapinePhenothiazines/adverse effectsPiperazines/adverse effectsQuetiapine FumarateQuinolones/adverse effectsRisperidone/adverse effectsSchizophrenia/drug therapyThiazoles/adverse effects
Substances： See more » Antipsychotic AgentsDibenzothiazepinesPhenothiazinesPiperazinesQuinolonesThiazolesBenzodiazepinesQuetiapine FumarateziprasidoneAripiprazoleClozapineRisperidoneOlanzapine
Year: 2007 PMID： 17713300 DOI： 10.1097/SMJ.0b013e318063e8ef
Source DB: PubMed Journal: South Med J ISSN： 0038-4348 Impact factor: 0.954